The global GLP-1 Drug Peptide API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
GLP-1 (Glucagon-Like Peptide-1) drugs are a class of drugs used to treat type 2 diabetes and obesity, usually prepared in the form of polypeptides. These drugs mimic the GLP-1 hormone in the body, causing the release of insulin and controlling blood sugar levels. Peptide APIs are the starting components of these drugs, typically synthesized or produced in laboratories and used in further formulation preparations.
This report is a detailed and comprehensive analysis for global GLP-1 Drug Peptide API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global GLP-1 Drug Peptide API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global GLP-1 Drug Peptide API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global GLP-1 Drug Peptide API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global GLP-1 Drug Peptide API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 Drug Peptide API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 Drug Peptide API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CPC Scientific, Novo Nordisk, Teva Pharmaceutical Industries Ltd, JYMedtech, Zhejiang Peptites Biotech, Shengnuo Biotechnology, Suzhou Tianma Pharmaceutical, SINOPEP, WuXi AppTec, HYBIO Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
GLP-1 Drug Peptide API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Semaglutide
Liraglutide
Tilpotide
Market segment by Application
Diabetes
Obesity
Other
Major players covered
CPC Scientific
Novo Nordisk
Teva Pharmaceutical Industries Ltd
JYMedtech
Zhejiang Peptites Biotech
Shengnuo Biotechnology
Suzhou Tianma Pharmaceutical
SINOPEP
WuXi AppTec
HYBIO Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GLP-1 Drug Peptide API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1 Drug Peptide API, with price, sales quantity, revenue, and global market share of GLP-1 Drug Peptide API from 2020 to 2025.
Chapter 3, the GLP-1 Drug Peptide API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1 Drug Peptide API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and GLP-1 Drug Peptide API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Drug Peptide API.
Chapter 14 and 15, to describe GLP-1 Drug Peptide API sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1 Drug Peptide API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Semaglutide
1.3.3 Liraglutide
1.3.4 Tilpotide
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1 Drug Peptide API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Diabetes
1.4.3 Obesity
1.4.4 Other
1.5 Global GLP-1 Drug Peptide API Market Size & Forecast
1.5.1 Global GLP-1 Drug Peptide API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global GLP-1 Drug Peptide API Sales Quantity (2020-2031)
1.5.3 Global GLP-1 Drug Peptide API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 CPC Scientific
2.1.1 CPC Scientific Details
2.1.2 CPC Scientific Major Business
2.1.3 CPC Scientific GLP-1 Drug Peptide API Product and Services
2.1.4 CPC Scientific GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 CPC Scientific Recent Developments/Updates
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk GLP-1 Drug Peptide API Product and Services
2.2.4 Novo Nordisk GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Novo Nordisk Recent Developments/Updates
2.3 Teva Pharmaceutical Industries Ltd
2.3.1 Teva Pharmaceutical Industries Ltd Details
2.3.2 Teva Pharmaceutical Industries Ltd Major Business
2.3.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Product and Services
2.3.4 Teva Pharmaceutical Industries Ltd GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.4 JYMedtech
2.4.1 JYMedtech Details
2.4.2 JYMedtech Major Business
2.4.3 JYMedtech GLP-1 Drug Peptide API Product and Services
2.4.4 JYMedtech GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 JYMedtech Recent Developments/Updates
2.5 Zhejiang Peptites Biotech
2.5.1 Zhejiang Peptites Biotech Details
2.5.2 Zhejiang Peptites Biotech Major Business
2.5.3 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Product and Services
2.5.4 Zhejiang Peptites Biotech GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Zhejiang Peptites Biotech Recent Developments/Updates
2.6 Shengnuo Biotechnology
2.6.1 Shengnuo Biotechnology Details
2.6.2 Shengnuo Biotechnology Major Business
2.6.3 Shengnuo Biotechnology GLP-1 Drug Peptide API Product and Services
2.6.4 Shengnuo Biotechnology GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Shengnuo Biotechnology Recent Developments/Updates
2.7 Suzhou Tianma Pharmaceutical
2.7.1 Suzhou Tianma Pharmaceutical Details
2.7.2 Suzhou Tianma Pharmaceutical Major Business
2.7.3 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Product and Services
2.7.4 Suzhou Tianma Pharmaceutical GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Suzhou Tianma Pharmaceutical Recent Developments/Updates
2.8 SINOPEP
2.8.1 SINOPEP Details
2.8.2 SINOPEP Major Business
2.8.3 SINOPEP GLP-1 Drug Peptide API Product and Services
2.8.4 SINOPEP GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 SINOPEP Recent Developments/Updates
2.9 WuXi AppTec
2.9.1 WuXi AppTec Details
2.9.2 WuXi AppTec Major Business
2.9.3 WuXi AppTec GLP-1 Drug Peptide API Product and Services
2.9.4 WuXi AppTec GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 WuXi AppTec Recent Developments/Updates
2.10 HYBIO Pharmaceutical
2.10.1 HYBIO Pharmaceutical Details
2.10.2 HYBIO Pharmaceutical Major Business
2.10.3 HYBIO Pharmaceutical GLP-1 Drug Peptide API Product and Services
2.10.4 HYBIO Pharmaceutical GLP-1 Drug Peptide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 HYBIO Pharmaceutical Recent Developments/Updates
3 Competitive Environment: GLP-1 Drug Peptide API by Manufacturer
3.1 Global GLP-1 Drug Peptide API Sales Quantity by Manufacturer (2020-2025)
3.2 Global GLP-1 Drug Peptide API Revenue by Manufacturer (2020-2025)
3.3 Global GLP-1 Drug Peptide API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of GLP-1 Drug Peptide API by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 GLP-1 Drug Peptide API Manufacturer Market Share in 2024
3.4.3 Top 6 GLP-1 Drug Peptide API Manufacturer Market Share in 2024
3.5 GLP-1 Drug Peptide API Market: Overall Company Footprint Analysis
3.5.1 GLP-1 Drug Peptide API Market: Region Footprint
3.5.2 GLP-1 Drug Peptide API Market: Company Product Type Footprint
3.5.3 GLP-1 Drug Peptide API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global GLP-1 Drug Peptide API Market Size by Region
4.1.1 Global GLP-1 Drug Peptide API Sales Quantity by Region (2020-2031)
4.1.2 Global GLP-1 Drug Peptide API Consumption Value by Region (2020-2031)
4.1.3 Global GLP-1 Drug Peptide API Average Price by Region (2020-2031)
4.2 North America GLP-1 Drug Peptide API Consumption Value (2020-2031)
4.3 Europe GLP-1 Drug Peptide API Consumption Value (2020-2031)
4.4 Asia-Pacific GLP-1 Drug Peptide API Consumption Value (2020-2031)
4.5 South America GLP-1 Drug Peptide API Consumption Value (2020-2031)
4.6 Middle East & Africa GLP-1 Drug Peptide API Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global GLP-1 Drug Peptide API Sales Quantity by Type (2020-2031)
5.2 Global GLP-1 Drug Peptide API Consumption Value by Type (2020-2031)
5.3 Global GLP-1 Drug Peptide API Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global GLP-1 Drug Peptide API Sales Quantity by Application (2020-2031)
6.2 Global GLP-1 Drug Peptide API Consumption Value by Application (2020-2031)
6.3 Global GLP-1 Drug Peptide API Average Price by Application (2020-2031)
7 North America
7.1 North America GLP-1 Drug Peptide API Sales Quantity by Type (2020-2031)
7.2 North America GLP-1 Drug Peptide API Sales Quantity by Application (2020-2031)
7.3 North America GLP-1 Drug Peptide API Market Size by Country
7.3.1 North America GLP-1 Drug Peptide API Sales Quantity by Country (2020-2031)
7.3.2 North America GLP-1 Drug Peptide API Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe GLP-1 Drug Peptide API Sales Quantity by Type (2020-2031)
8.2 Europe GLP-1 Drug Peptide API Sales Quantity by Application (2020-2031)
8.3 Europe GLP-1 Drug Peptide API Market Size by Country
8.3.1 Europe GLP-1 Drug Peptide API Sales Quantity by Country (2020-2031)
8.3.2 Europe GLP-1 Drug Peptide API Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific GLP-1 Drug Peptide API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific GLP-1 Drug Peptide API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific GLP-1 Drug Peptide API Market Size by Region
9.3.1 Asia-Pacific GLP-1 Drug Peptide API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific GLP-1 Drug Peptide API Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America GLP-1 Drug Peptide API Sales Quantity by Type (2020-2031)
10.2 South America GLP-1 Drug Peptide API Sales Quantity by Application (2020-2031)
10.3 South America GLP-1 Drug Peptide API Market Size by Country
10.3.1 South America GLP-1 Drug Peptide API Sales Quantity by Country (2020-2031)
10.3.2 South America GLP-1 Drug Peptide API Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa GLP-1 Drug Peptide API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa GLP-1 Drug Peptide API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa GLP-1 Drug Peptide API Market Size by Country
11.3.1 Middle East & Africa GLP-1 Drug Peptide API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa GLP-1 Drug Peptide API Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 GLP-1 Drug Peptide API Market Drivers
12.2 GLP-1 Drug Peptide API Market Restraints
12.3 GLP-1 Drug Peptide API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of GLP-1 Drug Peptide API and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1 Drug Peptide API
13.3 GLP-1 Drug Peptide API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1 Drug Peptide API Typical Distributors
14.3 GLP-1 Drug Peptide API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
CPC Scientific
Novo Nordisk
Teva Pharmaceutical Industries Ltd
JYMedtech
Zhejiang Peptites Biotech
Shengnuo Biotechnology
Suzhou Tianma Pharmaceutical
SINOPEP
WuXi AppTec
HYBIO Pharmaceutical
听
听
*If Applicable.
